Medical Alert Jewelry for Breast Cancer
Links shared publicly online about this topic
Men For A Cause, United Against Breast Cancer: Medical News: FDA Okays Drug Combo for Advanced Breast Cancer - in Product Alert, Prescriptions from MedPage Today
mybreastcancerawareness.blogspot.com — “Men For A Cause, United Against Breast Cancer: Medical News: FDA Okays Drug Combo for Advanced Breast Cancer - in Product Alert, Prescriptions from MedPage Today” View full resource at mybreastcancerawareness.blogspot.com
Most Recently Shared on February 1, 2010 at 9:44 am By:
Men For A Cause (TM) Health Organization
Medical News: FDA Okays Drug Combo for Advanced Breast Cancer - in Product Alert… http://goo.gl/fb/KVkz
Men For A Cause, United Against Breast Cancer: Medical News: FDA Okays Drug Combo for Advanced Breast Cancer - in Product Alert, Prescriptions from MedPage Today
mybreastcancerawareness.blogspot.com — “Men For A Cause, United Against Breast Cancer: Medical News: FDA Okays Drug Combo for Advanced Breast Cancer - in Product Alert, Prescriptions from MedPage Today” View full resource at mybreastcancerawareness.blogspot.com
Most Recently Shared on February 1, 2010 at 9:40 am By:
Men For A Cause (TM) Health Organization
Medical News: FDA Okays Drug Combo for Advanced Breast Cancer - in Product Alert… http://goo.gl/fb/qjpt
Medical News: FDA Expands Agent's Orphan Drug Status - in Product Alert, Prescriptions from MedPage Today
medpagetoday.com — “WASHINGTON -- The FDA has extended the orphan drug status of the breast cancer agent protein-bound paclitaxel (Abraxane) for use in stage IIB-IV melanoma treatment.” View full resource at medpagetoday.com
Most Recently Shared on November 6, 2009 at 1:00 pm By:
FDA Expands Agent's Orphan Drug Status http://bit.ly/2vwwYq
To better predict breast cancer outcomes - QualityPoint Technologies
qualitypointtech.net — “Scientists from McGill University's Rosalind and Morris Goodman Cancer Research Centre (GCRC), the Research Institute of the McGill University Health Centre (RI MUHC), the Dana-Farber Cancer Institute and Harvard Medical School have discovered a gene signature that can accurately predict which patients with breast cancer are at risk of relapse, thereby sparing those who are not from the burdens linked to unnecessary therapy........ (Source: Medicineworld.org: New Article Alert)” View full resource at qualitypointtech.net
Most Recently Shared on January 28, 2011 at 1:01 pm By:
To better predict breast cancer outcomes: Scientists from McGill University's Rosalind and Morris Goodman Cancer ... http://bit.ly/ianggL
Study helps eliminate causes for joint pain linked to commonly used breast cancer drugs
eurekalert.org — “Researchers exploring why some women who take a common breast cancer drug develop serious joint pain have eliminated two possible causes: Inflammatory arthritis and autoimmune disease. Because of these findings, researchers say women should be encouraged to continue taking the medication to gain its full benefit.” View full resource at eurekalert.org
Most Recently Shared on November 11, 2011 at 5:48 am By:
AAAS Study helps eliminate causes for joint pain linked to commonly used breast cancer drugs http://t.co/y1T4nreL
Medical News: Implant Focus Shifts to Rarity of Implant-Related Cancer - in Product Alert, Devices and Vaccines from MedPage Today
medpagetoday.com — “A mix of caution, approval, and a touch of I-told-you-so greeted the FDA announcement that breast implants have been linked to a rare form of lymphoma.” View full resource at medpagetoday.com
Most Recently Shared on January 28, 2011 at 3:09 am By:
Implant Focus Shifts to Rarity of Implant-Related Cancer http://bit.ly/gv3l0r
Anti-estrogen medication reduces risk of dying from lung cancer - QualityPoint Technologies
qualitypointtech.net — “(Wiley-Blackwell) A new study has found that tamoxifen, an anti-estrogen breast cancer medication, may reduce an individual's risk of death from lung cancer. Published early online in Cancer, a peer-reviewed journal of the American Cancer Society, the study supports the hypothesis that there is a hormonal influence on lung cancer and that estrogen levels play a role in lung cancer patients' prognosis. (Source: EurekAlert! - Medicine and Health)” View full resource at qualitypointtech.net
Most Recently Shared on January 24, 2011 at 8:02 am By:
Anti-estrogen medication reduces risk of dying from lung cancer: (Wiley-Blackwell) A new study has found that tamo... http://bit.ly/ff6J3G
Are drugs lurking in your dietary supplements? - Harvard Health Publications
health.harvard.edu — “Harvard Health Blog: You'll find posts from Harvard Medical School physicians and our editors on a variety of health news and issues.” View full resource at health.harvard.edu
Most Recently Shared on October 4, 2010 at 6:23 pm By:
Are drugs lurking in your dietary supplements? P.J. Skerrett, Editor, Harvard Heart Letter discusses - http://bit.ly/bzG3nY
The Top 3 resources shared on this topic. More resources.
Key stats and trends about this topic
Featuring the top 3 experts for this topic
-
Men For A Cause (TM)
Men For A Cause,is a national nonprofit founded to educate, motivate and empower men in the fight against breast cancer in both women and men internationally
-
Men For A Cause (TM)
Men For A Cause,is a national nonprofit founded to educate, motivate and empower men in the fight against breast cancer in both women and men internationally
-
FightCancer
Cancer news feed, formerly part of a blog. RSS suggestions welcome.
Advertisement
